Sean Hammond, PhD

Solriamfetol for Excessive Sleepiness in Narcolepsy and Obstructive Sleep Apnea: Effect Sizes and Numbers Needed to Treat or Harm

This post-hoc analysis of two phase 3 studies demonstrates that solriamfetol, an approved treatment for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea, ...

Sean Hammond , PhD;

10/26/2023

Featured CME

The Medication Access and Training Expansion (MATE) Act requires prescribers renewing their DEA registration to have completed at least 8 hours of training on opioid or other substance use disorders.

Upcoming Events

April 5 ⁠–⁠ April 6

April 21 ⁠–⁠ April 24

April 29 ⁠–⁠ April 30

April 30 ⁠–⁠ May 4

May 1 ⁠–⁠ May 2

May 7 ⁠–⁠ May 9

May 8 ⁠–⁠ May 10

May 14 ⁠–⁠ May 16

May 19 ⁠–⁠ May 21

May 28 ⁠–⁠ May 31

See Full Calendar

Sean Hammond, PhD

Featured CME

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products